Seven new NICE Medtech Innovation Briefings published

Published: 6-Jul-2015

Documents help NHS and social care commissioners considering using new medical devices and other medical or diagnostic technologies

A compression system for treating venous leg ulcers, a test for diagnosing gastro-oesophageal reflux, and a treatment for dry eyes are among seven new Medtech Innovation Briefings published by the National Institute for Health and Care Excellence (NICE).

The documents are a new product from NICE to support NHS and social care commissioners and staff who are considering using new medical devices and other medical or diagnostic technologies.

The information provided includes a description of the technology, how it’s used, and its potential role in the treatment pathway. The briefings also include a review of relevant published evidence and the likely costs of using the technology, but they are not guidance and do not make any recommendations on the value of using the technologies. Whether or not to use the products described is entirely the choice of local staff. However, the briefings will avoid the need for organisations to produce similar information, so saving staff time, effort and resources.

The latest Medtech Innovation Briefings cover:

  • The Juxta CURES adjustable compression system for treating venous leg ulcers - CircAid Medical Products (click here)
  • The PediGuard for placing pedicle screws in spinal surgery - SpineGuard (click here)
  • The Prosigna gene expression profiling assay for assessing the long-term risk of breast cancer recurrence - NanoString Technologies (click here)
  • Xpert test for the intrapartum detection of group B streptococcus - Cepheid(click here)
  • LipiFlow thermal pulsation treatment for dry eyes caused by blocked meibomian glands - TearScience (click here)
  • LARS for reconstructing damaged intra-articular cruciate knee ligaments - Corin Group(click here)
  • Peptest for diagnosing gastro-oesophageal reflux - RD Biomed(click here)

The briefings are commissioned by NHS England and produced in support of the NHS 5 Year Forward View, specifically as one of a number of steps that will accelerate innovation in new treatments and diagnostics. It’s hoped this impartial information about innovative devices and diagnostics will help NHS and social care professionals and buyers and commissioners of services with their local decision-making.



You may also like